Education
About Us
Working with TipRanks
Follow Us
ATAI Life Sciences (ATAI)
NASDAQ:ATAI
Total Valuation
ATAI Life Sciences has a market cap or net worth of $405.52M. The enterprise value is $238.72M.
Market Cap$405.52M
Enterprise Value$238.72M
Share Statistics
ATAI Life Sciences has 200,752,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding200,752,780
Owned by Insiders33.07%
Owned by Institutions3.98%
Financial Efficiency
ATAI Life Sciences’s return on equity (ROE) is -1.28 and return on invested capital (ROIC) is -71.01%.
Return on Equity (ROE)-1.28
Return on Assets (ROA)-0.94
Return on Invested Capital (ROIC)-71.01%
Return on Capital Employed (ROCE)-0.76
Revenue Per Employee5.70K
Profits Per Employee-2.78M
Employee Count54
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ATAI Life Sciences is -1.43. ATAI Life Sciences’s PEG ratio is -0.30.
PE Ratio-1.43
PS Ratio0.00
PB Ratio1.59
Price to Fair Value1.83
Price to FCF-3.93
Price to Operating Cash Flow-3.97
PEG Ratio-0.30
Income Statement
In the last 12 months, ATAI Life Sciences had revenue of 308.00K and earned -149.27M in profits. Earnings per share was -0.93.
Revenue308.00K
Gross Profit1.55M
Operating Income-102.69M
Pretax Income-148.41M
Net Income-149.27M
EBITDA-145.33M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -77.70M and capital expenditures -90.00K, giving a free cash flow of -77.80M billion.
Operating Cash Flow-77.70M
Free Cash Flow-77.80M
Free Cash Flow per Share-0.39
Dividends & Yields
ATAI Life Sciences pays an annual dividend of $6, resulting in a dividend yield of ―
Dividend Per Share$6
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.59
52-Week Price Change66.67%
50-Day Moving Average1.86
200-Day Moving Average1.56
Relative Strength Index (RSI)52.72
Average Volume (3m)2.76M
Important Dates
ATAI Life Sciences upcoming earnings date is Aug 18, 2025, Before Open (Confirmed).
Last Earnings DateMay 14, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend DateAug 27, 2018
Financial Position
ATAI Life Sciences as a current ratio of 3.21, with Debt / Equity ratio of 5.80%
Current Ratio3.21
Quick Ratio3.21
Debt to Market Cap0.11
Net Debt to EBITDA-0.05
Interest Coverage Ratio-32.87
Taxes
In the past 12 months, ATAI Life Sciences has paid -356.00K in taxes.
Income Tax-356.00K
Effective Tax Rate<0.01
Enterprise Valuation
ATAI Life Sciences EV to EBITDA ratio is -1.52, with an EV/FCF ratio of -2.67.
EV to Sales714.98
EV to EBITDA-1.52
EV to Free Cash Flow-2.67
EV to Operating Cash Flow-2.67
Balance Sheet
ATAI Life Sciences has $58.29M in cash and marketable securities with $14.24M in debt, giving a net cash position of -$44.05M billion.
Cash & Marketable Securities$58.29M
Total Debt$14.24M
Net Cash-$44.05M
Net Cash Per Share-$0.22
Tangible Book Value Per Share$0.71
Margins
Gross margin is 27.90%, with operating margin of -33341.23%, and net profit margin of -48463.96%.
Gross Margin27.90%
Operating Margin-33341.23%
Pretax Margin-48183.44%
Net Profit Margin-48463.96%
EBITDA Margin-47186.04%
EBIT Margin-47169.16%
Analyst Forecast
The average price target for ATAI Life Sciences is $8.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.80
Price Target Upside317.06% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-0.90%
EPS Growth Forecast-89.51%